Last edition
News about "Astellas Pharma Inc"
Astellas Advances Setidegrasib Into Phase 3 Trial for NSCLC
Astellas has dosed the first patient in a Phase 3 study evaluating setidegrasib against docetaxel in patients with KRAS G12D-mutated NSCLC.
Astellas Pharma Inc | 25/09/2026 | By News Bureau
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood
Astellas Pharma Inc | 14/08/2023 | By Sudeep Soparkar | 1048
Verizon Business selected to transform Astellas Pharma's global network infra
Digital transformation is seen as critical enabler in delivering improved patient outcomes and future growth
Astellas Pharma Inc | 10/08/2022 | By Sudeep Soparkar | 1494
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy